Chemcrux Enterprises Profit & Loss Annual

Trade
BSE: 540395 | NSE: - | ISIN: INE298W01016 | Sector: Biotechnology & Drugs
186.10 +1.20 (0.65%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 78.4795.1595.2753.33
Total Revenue 78.4795.1595.2753.33
Costof Revenue Total 31.1342.9947.8720.78
Gross Profit 47.3352.1647.4032.55
Selling/ General/ Admin Expenses Total 8.837.916.326.12
Depreciation/ Amortization 2.292.041.591.20
Other Operating Expenses Total 25.2922.8020.3813.83
Total Operating Expense 67.5475.7476.1541.93
Operating Income 10.9319.4119.1211.40
Interest Inc( Exp) Net- Non- Op Total -8.32-0.750.73-1.02
Other Net 1.340.290.720.75
Net Income Before Taxes 11.4319.6519.9512.05
Provisionfor Income Taxes 2.995.295.093.11
Net Income After Taxes 8.4414.3614.868.93
Net Income Before Extra Items 8.4414.3614.868.93
Net Income 8.4414.3614.868.93
Income Availableto Com Excl Extra Ord 8.4414.3614.868.93
Income Availableto Com Incl Extra Ord 8.4414.3614.868.93
Diluted Net Income 8.4414.3614.868.93
Diluted Weighted Average Shares 1.481.481.480.49
Diluted EPS Excluding Extra Ord Items 5.709.7010.0318.10
DPS- Common Stock Primary Issue 1.002.002.002.00
Diluted Normalized EPS 5.709.6910.0118.10
Gain( Loss)on Saleof Assets -0.170.390.00
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts